In vitro susceptibility of various genotypic strains of Toxoplasma gondii to pyrimethamine, sulfadiazine, and atovaquone.

Antimicrobial Agents and Chemotherapy
Pascale MeneceurF Derouin

Abstract

Sulfadiazine, pyrimethamine, and atovaquone are widely used for the treatment of severe toxoplasmosis. Their in vitro activities have been almost exclusively demonstrated on laboratory strains belonging to genotype I. We determined the in vitro activities of these drugs against 17 strains of Toxoplasma gondii belonging to various genotypes and examined the correlations among 50% inhibitory concentrations (IC50s), growth kinetics, strain genotypes, and mutations on drug target genes. Growth kinetics were determined in THP-1 cell cultures using real-time PCR. IC50s were determined in MRC-5 cell cultures using a T. gondii-specific enzyme-linked immunosorbent assay performed on cultures. Mutations in dihydrofolate reductase (DHFR), dihydropteroate synthase (DHPS), and cytochrome b genes were determined by sequencing. Pyrimethamine IC50s ranged between 0.07 and 0.39 mg/liter, with no correlation with the strain genotype but a significant correlation with growth kinetics. Several mutations found on the DHFR gene were not linked to lower susceptibility. Atovaquone IC50s were in a narrow range of concentrations (mean, 0.06 +/- 0.02 mg/liter); no mutation was found on the cytochrome b gene. IC50s for sulfadiazine ranged between 3 and 18...Continue Reading

References

Aug 1, 1992·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·B J Luft, J S Remington
May 1, 1992·Experimental Parasitology·E R PfefferkornR F Nothnagel
Feb 1, 1992·Antimicrobial Agents and Chemotherapy·F G AraujoJ S Remington
Oct 1, 1989·Antimicrobial Agents and Chemotherapy·F Derouin, C Chastang
Feb 1, 1987·The Journal of Clinical Investigation·C J AllegraH Masur
Jan 1, 1988·The Journal of Infectious Diseases·C HarrisM Wittner
Mar 1, 1988·Antimicrobial Agents and Chemotherapy·F Derouin, C Chastang
Aug 1, 1980·International Journal of Cancer. Journal International Du Cancer·S TsuchiyaK Tada
Dec 1, 1995·The Journal of Infectious Diseases·D K Howe, L D Sibley
Dec 15, 1993·Proceedings of the National Academy of Sciences of the United States of America·R G Donald, D S Roos
Aug 1, 1995·The Journal of Antimicrobial Chemotherapy·P WinstanleyS Watkin
Mar 1, 1997·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R A TorresJ Scott
Sep 26, 1997·Antimicrobial Agents and Chemotherapy·D C McFaddenJ C Boothroyd
Feb 22, 2001·The Journal of Infectious Diseases·P KazanjianS R Meshnick
Mar 31, 2001·Transactions of the Royal Society of Tropical Medicine and Hygiene·H S NageshaA F Cowman
Jun 23, 2001·Molecular and Biochemical Parasitology·J R RadkeM W White
Jul 28, 2001·The Journal of Infectious Diseases·M E GriggT P Margolis
Jul 1, 1958·The American Journal of Tropical Medicine and Hygiene·M K COOK
May 21, 2004·British Journal of Clinical Pharmacology·T TrenqueS Urien
Jun 15, 2004·Lancet·J G Montoya, O Liesenfeld
Sep 24, 2004·International Journal for Parasitology·François PeyronStéphane Picot
Sep 25, 2004·Antimicrobial Agents and Chemotherapy·Stéphane CorvaisierFrançois Peyron
Apr 9, 2005·Journal of Clinical Microbiology·Daniel AjzenbergMarie-Laure Dardé
Sep 15, 2005·Molecular and Biochemical Parasitology·Kristen M MassimineIsabelle Coppens
Jan 18, 2006·Molecular and Biochemical Parasitology·Jacques J KesslBernard L Trumpower
Mar 7, 2006·Journal of Clinical Microbiology·S CassaingJ F Magnaval
May 19, 2006·Emerging Infectious Diseases·Asis KhanL David Sibley
Jun 13, 2006·Ocular Immunology and Inflammation·Holger BaatzLars-Olof Hattenbach
Feb 20, 2007·PLoS Pathogens·Hiba El HajjJean François Dubremetz
Apr 4, 2007·Expert Review of Anti-infective Therapy·Eskild Petersen

❮ Previous
Next ❯

Citations

Jun 19, 2013·Parasitology Research·Xing-Xing HuoJi-Long Shen
Jan 1, 2012·Asian Pacific Journal of Tropical Biomedicine·Yan-Bo ZengBing Huang
Sep 29, 2012·Proceedings of the National Academy of Sciences of the United States of America·J Stone DoggettMichael K Riscoe
May 12, 2012·The Journal of Biological Chemistry·Djeneb CamaraFabrice Rébeillé
Jan 14, 2009·Infection and Immunity·Catrine M PerssonBenedict J Chambers
May 17, 2013·American Journal of Respiratory and Critical Care Medicine·Vincent SobanskiNicolas Just
Oct 31, 2009·Genetics, Selection, Evolution : GSE·Anna WolcWilliam G Hill
May 12, 2009·Memórias do Instituto Oswaldo Cruz·Rima McLeodHerve Pelloux
Apr 22, 2011·The Journal of Parasitology·Qing TaoJunlong Zhao
Mar 26, 2009·International Journal of Medical Sciences·Yan Guex-Crosier
May 28, 2013·Parasite : Journal De La Société Française De Parasitologie·Christelle DoliwaIsabelle Villena
Jul 11, 2014·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Katarzyna DzitkoPiotr Paneth
Nov 15, 2011·Trends in Parasitology·Florence Robert-GangneuxHervé Pelloux
Aug 3, 2010·Bioorganic & Medicinal Chemistry Letters·Molla M EndeshawKarl A Werbovetz
Jun 2, 2009·Bioorganic & Medicinal Chemistry·Pierre VerhaeghePatrice Vanelle
Aug 1, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Guilherme Sturzeneker Cerqueira LimaFábio Petersen Saraiva
May 26, 2009·Molecular and Biochemical Parasitology·Virginie SauvageIsabelle Villena
Jun 29, 2010·Prenatal Diagnosis·Laurence DelhaesVéronique Houfflin-Debarge
Aug 15, 2015·Parasites & Vectors·Katarzyna DzitkoHenryka Długońska
Feb 18, 2014·International Journal for Parasitology. Drugs and Drug Resistance·Christelle DoliwaIsabelle Villena
Sep 25, 2012·Experimental Parasitology·Ronize Andréia FerreiraRicardo Wagner de Almeida Vitor
Dec 5, 2012·Experimental Parasitology·C DoliwaI Villena
Nov 21, 2008·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·F DerouinUNKNOWN ESCMID Study Group on Clinical Parasitology
May 18, 2016·Nanoscale·Yulan WangYufeng Zhang
Apr 20, 2006·Molecular and Biochemical Parasitology·Sonia M Robles LopezBarbara H Zimmermann
Aug 27, 2016·Canadian Journal of Physiology and Pharmacology·Mahdi SharifAhmad Daryani
Nov 21, 2009·European Journal of Medicinal Chemistry·Youssef KabriPatrice Vanelle
Jun 9, 2016·Memórias do Instituto Oswaldo Cruz·Claudio Bs OliveiraValter F Andrade-Neto
Aug 30, 2012·Revista Da Sociedade Brasileira De Medicina Tropical·Thaís Cobellis GomesVicente Amato-Neto
May 12, 2009·Memórias do Instituto Oswaldo Cruz·M R Stanford, R E Gilbert
Aug 21, 2014·European Journal of Medicinal Chemistry·Melissa D'AscenzioLorraine Jones-Brando
Feb 7, 2017·Frontiers in Microbiology·Mahbobeh MontazeriAhmad Daryani
Nov 15, 2017·Antimicrobial Agents and Chemotherapy·Jérémy SpalenkaIsabelle Villena
Jun 17, 2015·Antimicrobial Agents and Chemotherapy·Loyze Paola O de LimaHelene S Barbosa
Oct 8, 2014·Antimicrobial Agents and Chemotherapy·Katarzyna DzitkoPiotr Paneth

❮ Previous
Next ❯

Related Concepts

Related Feeds

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.